DAVID
GARCIA AZORIN
PROFESOR ASOCIADO
Instituto de Investigación Sanitaria Aragón
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Aragón (9)
2024
-
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937
-
Visual snow syndrome in patients with migraine: widening the clinical spectrum of the syndrome with permanent and episodic manifestations
Neurological Sciences, Vol. 45, Núm. 9, pp. 4437-4444
2023
-
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry
Journal of Headache and Pain, Vol. 24, Núm. 1
-
Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group
Neurologia, Vol. 38, Núm. 9, pp. 635-646
2021
-
Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown
Neurological Sciences, Vol. 42, Núm. 12, pp. 5087-5092
-
Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology COVID-19 Registry
Neurologia, Vol. 36, Núm. 2, pp. 127-134
-
Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine
Pain medicine (Malden, Mass.), Vol. 22, Núm. 9, pp. 2079-2091
2020
-
Impact of the COVID-19 pandemic on headache management in Spain: an analysis of the current situation and future perspectives
Neurologia, Vol. 35, Núm. 6, pp. 372-380